Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
11th Jul 20182:27 pmRNSDirector/PDMR Shareholding
21st Jun 20187:00 amRNSDirector/PDMR Shareholding
12th Jun 20184:04 pmRNSDirector/PDMR Shareholding
11th Jun 20182:02 pmRNSDirector/PDMR Shareholding
31st May 20183:41 pmRNSDirector/PDMR Shareholding
25th May 20182:09 pmRNSDirector/PDMR Shareholding
11th May 20184:31 pmRNSDirector/PDMR Shareholding
26th Apr 20183:57 pmRNSDirector/PDMR Shareholding
26th Apr 20189:16 amRNSResult of AGM
25th Apr 20187:00 amRNSTrading Update for the First Quarter 2018
20th Apr 201811:14 amRNSDirectorate Change
20th Apr 20187:00 amRNSDirectorate Change
19th Apr 20189:47 amRNSDirector/PDMR Shareholding
19th Apr 20189:44 amRNSDirector/PDMR Shareholding
11th Apr 20181:09 pmRNSDirector/PDMR Shareholding
11th Apr 20187:00 amRNSCapital Markets Event
3rd Apr 20182:19 pmRNSDirector/PDMR Shareholding
28th Mar 20182:39 pmRNSDirector/PDMR Shareholding
28th Mar 20182:38 pmRNSDirector/PDMR Shareholding
28th Mar 201812:19 pmRNSScheme of Arrangement becomes Effective
26th Mar 201812:09 pmRNSDirector/PDMR Shareholding - Replacement
22nd Mar 20182:41 pmRNSDirector/PDMR Shareholding
21st Mar 20183:16 pmRNSDirector/PDMR Shareholding
21st Mar 20182:56 pmRNSDirector/PDMR Shareholding
19th Mar 20185:45 pmRNSAnnual Financial Report
16th Mar 20181:47 pmRNSDirector/PDMR Shareholding
13th Mar 20182:18 pmRNSDirector/PDMR Shareholding
12th Mar 20182:03 pmRNSDirector/PDMR Shareholding
8th Mar 201811:20 amRNSDirector/PDMR Shareholding
8th Mar 201811:19 amRNSDirector/PDMR Shareholding
8th Mar 201811:18 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:17 amRNSDirector/PDMR Shareholding
8th Mar 201811:16 amRNSDirector/PDMR Shareholding
8th Mar 201811:15 amRNSDirector/PDMR Shareholding
8th Mar 201811:13 amRNSDirector/PDMR Shareholding
8th Mar 201811:10 amRNSDirector/PDMR Shareholding
8th Mar 201811:08 amRNSDirector/PDMR Shareholding
2nd Mar 20184:41 pmRNSTransaction in Own Shares
28th Feb 201810:19 amRNSReplacement:Results for the year ended 31 Dec 2017
27th Feb 20187:00 amRNSDirectorate Change
27th Feb 20187:00 amRNSResults for the year ended 31 December 2017
26th Feb 20183:34 pmRNSPublication of Scheme Document
26th Feb 20189:08 amRNSForm 8 (OPD) PLANT IMPACT PLC
16th Feb 20187:00 amRNSRecommended cash offer
15th Feb 20185:14 pmRNSDirector/PDMR Shareholding
13th Feb 20184:51 pmRNSDirector/PDMR Shareholding
11th Jan 20184:47 pmRNSDirector/PDMR Shareholding
11th Jan 20181:00 pmRNSTechnology acquisitions
12th Dec 20172:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.